Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment-Reference-Cited by-同舟云学术

Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment

Published:2016-05-20 Issue:5 Volume:137 Page:820-837
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J. Neurochem.

Author:

Wagner Leona¹²³,Björkqvist Maria⁴,Lundh Sofia Hult⁵,Wolf Raik²⁶,Börgel Arne²⁷,Schlenzig Dagmar⁸,Ludwig Hans-Henning²,Rahfeld Jens-Ulrich⁸,Leavitt Blair⁹,Demuth Hans-Ulrich⁸,Petersén Åsa⁵,von Hörsten Stephan³^ORCID

Affiliation:

1. Deutschsprachige Selbsthilfegruppe für Alkaptonurie (DSAKU) e.V.; Stuttgart Germany

2. Probiodrug AG; Halle (Saale) Germany

3. Department of Experimental Therapy; Franz-Penzoldt-Center; Friedrich-Alexander-University Erlangen-Nürnberg; Erlangen Germany

4. Brain Disease Biomarker Unit; Department of Experimental Medical Science; Wallenberg Neuroscience Centre; Lund University; Lund Sweden

5. Translational Neuroendocrine Research Unit; Lund University; Lund Sweden

6. Center for Clinical Chemistry, Microbiology and Transfusion; Klinikum St. Georg GmbH; Leipzig Germany

7. Institute of Molecular Biology (IMB); Johannes Gutenberg-University Mainz; Mainz Germany

8. Department of Drug Design and Target Validation; Fraunhofer-Institute for Cell Therapy and Immunology; Halle (Saale) Germany

9. The Centre for Molecular Medicine and Therapeutics Child and Family Research Institute; BC Children's Hospital; The University of British Columbia; Vancouver British Columbia

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jnc.13624/fullpdf

Reference99 articles.

1. Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35, a new peptide cleaved by plasma kallikrein;Abid;J. Biol. Chem.,2009

2. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8;Acker;J. Neurochem.,1987

3. Separation of biological proteins by liquid chromatography;Ali;Saudi Pharm. J.,2010

4. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease;Araujo;Neuroscience,1997

5. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease;Aziz;J. Clin. Endocrinol. Metab.,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of Human Juvenile Huntington’s Disease Brain Proteomes in Cortex and Putamen Involves Mitochondrial and Neuropeptide Systems;Journal of Huntington's Disease;2023-12-15

2. Transplanted human neural stem cells rescue phenotypes in zQ175 Huntington’s disease mice and innervate the striatum;Molecular Therapy;2023-12

3. Cross talk about the role of Neuropeptide Y in CNS disorders and diseases;Neuropeptides;2023-12

4. Dynorphin 1-17 biotransformation peptides: properties, challenges and solutions for future therapeutics development;Future Medicinal Chemistry;2023-05

5. A Glimpse of Molecular Biomarkers in Huntington’s Disease;International Journal of Molecular Sciences;2022-05-12